Agios Pharmaceuticals, Inc. (AGIO)
33.60
-0.04
(-0.12%)
USD |
NASDAQ |
Sep 11, 16:00
33.59
-0.01
(-0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Price : 33.60 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 33.94 | 34.28 | 33.32 | 33.60 | 750171.0 |
| Sep 10, 2026 | 34.26 | 35.28 | 33.21 | 33.64 | 720256.0 |
| Sep 09, 2026 | 33.14 | 35.38 | 33.14 | 34.63 | 1.025M |
| Sep 08, 2026 | 32.53 | 33.93 | 32.23 | 33.55 | 816359.0 |
| Sep 04, 2026 | 33.13 | 33.50 | 32.92 | 33.10 | 480162.0 |
| Sep 03, 2026 | 34.28 | 34.39 | 32.95 | 33.13 | 516035.0 |
| Sep 02, 2026 | 34.49 | 34.93 | 33.54 | 34.13 | 771682.0 |
| Sep 01, 2026 | 33.60 | 34.34 | 33.21 | 34.21 | 926955.0 |
| Aug 31, 2026 | 33.09 | 33.86 | 32.93 | 33.68 | 1.110M |
| Aug 28, 2026 | 33.94 | 34.36 | 33.27 | 33.32 | 519740.0 |
| Aug 27, 2026 | 33.94 | 34.80 | 33.60 | 34.28 | 1.001M |
| Aug 26, 2026 | 33.84 | 34.43 | 33.24 | 33.99 | 812040.0 |
| Aug 25, 2026 | 32.85 | 34.26 | 32.84 | 33.90 | 742189.0 |
| Aug 24, 2026 | 33.25 | 33.25 | 32.61 | 32.64 | 635735.0 |
| Aug 21, 2026 | 33.62 | 34.08 | 32.95 | 33.09 | 577553.0 |
| Aug 20, 2026 | 34.64 | 35.08 | 33.61 | 33.63 | 697493.0 |
| Aug 19, 2026 | 35.40 | 35.98 | 34.57 | 35.12 | 1.690M |
| Aug 18, 2026 | 33.53 | 34.83 | 33.46 | 34.40 | 1.188M |
| Aug 17, 2026 | 33.66 | 33.98 | 33.22 | 33.63 | 969285.0 |
| Aug 14, 2026 | 33.10 | 33.81 | 32.48 | 33.56 | 1.124M |
| Aug 13, 2026 | 34.35 | 34.65 | 33.31 | 33.47 | 939123.0 |
| Aug 12, 2026 | 32.74 | 34.31 | 32.33 | 34.21 | 1.223M |
| Aug 11, 2026 | 33.05 | 33.61 | 32.22 | 32.69 | 938748.0 |
| Aug 10, 2026 | 31.87 | 33.10 | 31.71 | 32.59 | 1.072M |
| Aug 07, 2026 | 32.32 | 32.61 | 31.54 | 32.27 | 1.400M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Biogen, Inc. | 217.15 |
| Insmed, Inc. | 129.41 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
Price Related Metrics
| PS Ratio | 20.05 |
| Price to Book Value | 1.952 |
| Earnings Yield | -20.86% |
| Market Cap | 2.003B |